CS236487B2 - Method of heptadecapeptide preparation - Google Patents

Method of heptadecapeptide preparation Download PDF

Info

Publication number: CS236487B2
Authority: CS; Czechoslovakia
Prior art keywords: arg; heptadecapeptide; leu; lys; purified
Prior art date: 1981-07-21

Application number

CS825579A

Other languages

Czech (cs)

English (en)

Inventor

Shinro Tachibana

Kengo Araki

Shizuko Ohya

Seiji Yoshida

Original Assignee

Eisai Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1981-07-21

Filing date

1982-07-21

Publication date

1985-05-15

1982-07-21 Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd

1985-05-15 Publication of CS236487B2 publication Critical patent/CS236487B2/cs

Links

238000000034 method Methods 0.000 title claims abstract description 19
238000002360 preparation method Methods 0.000 title abstract description 5
210000001198 duodenum Anatomy 0.000 claims abstract description 8
230000000694 effects Effects 0.000 claims abstract description 8
238000004128 high performance liquid chromatography Methods 0.000 claims description 6
238000002523 gelfiltration Methods 0.000 claims description 5
239000004375 Dextrin Substances 0.000 claims description 4
229920001353 Dextrin Polymers 0.000 claims description 4
235000019425 dextrin Nutrition 0.000 claims description 4
238000004108 freeze drying Methods 0.000 claims description 3
238000004587 chromatography analysis Methods 0.000 claims description 2
229940005483 opioid analgesics Drugs 0.000 claims description 2
229920002401 polyacrylamide Polymers 0.000 claims description 2
229920002134 Carboxymethyl cellulose Polymers 0.000 claims 1
235000010948 carboxy methyl cellulose Nutrition 0.000 claims 1
239000001768 carboxy methyl cellulose Substances 0.000 claims 1
239000008112 carboxymethyl-cellulose Substances 0.000 claims 1
238000004519 manufacturing process Methods 0.000 claims 1
CXHHBNMLPJOKQD-UHFFFAOYSA-N methyl hydrogen carbonate Chemical compound COC(O)=O CXHHBNMLPJOKQD-UHFFFAOYSA-N 0.000 claims 1
238000005185 salting out Methods 0.000 claims 1
238000000746 purification Methods 0.000 abstract description 5
238000000605 extraction Methods 0.000 abstract description 4
230000000202 analgesic effect Effects 0.000 abstract description 3
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000000243 solution Substances 0.000 description 18
108090000765 processed proteins & peptides Proteins 0.000 description 13
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
239000012634 fragment Substances 0.000 description 11
239000000126 substance Substances 0.000 description 9
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 8
150000001413 amino acids Chemical class 0.000 description 8
230000008602 contraction Effects 0.000 description 8
235000001014 amino acid Nutrition 0.000 description 7
229940024606 amino acid Drugs 0.000 description 7
150000001875 compounds Chemical class 0.000 description 7
239000000499 gel Substances 0.000 description 7
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
239000000203 mixture Substances 0.000 description 6
230000015556 catabolic process Effects 0.000 description 5
238000006731 degradation reaction Methods 0.000 description 5
210000003205 muscle Anatomy 0.000 description 5
239000012071 phase Substances 0.000 description 5
241000700199 Cavia porcellus Species 0.000 description 4
URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 description 4
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
102000055135 Vasoactive Intestinal Peptide Human genes 0.000 description 4
108010003205 Vasoactive Intestinal Peptide Proteins 0.000 description 4
230000007062 hydrolysis Effects 0.000 description 4
238000006460 hydrolysis reaction Methods 0.000 description 4
BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 4
229940127240 opiate Drugs 0.000 description 4
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
108010049140 Endorphins Proteins 0.000 description 3
102000009025 Endorphins Human genes 0.000 description 3
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
241000282898 Sus scrofa Species 0.000 description 3
102000004142 Trypsin Human genes 0.000 description 3
108090000631 Trypsin Proteins 0.000 description 3
239000004480 active ingredient Substances 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
238000004166 bioassay Methods 0.000 description 3
210000003405 ileum Anatomy 0.000 description 3
VBUWHHLIZKOSMS-RIWXPGAOSA-N invicorp Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=C(O)C=C1 VBUWHHLIZKOSMS-RIWXPGAOSA-N 0.000 description 3
238000002156 mixing Methods 0.000 description 3
239000008055 phosphate buffer solution Substances 0.000 description 3
150000003839 salts Chemical class 0.000 description 3
239000012588 trypsin Substances 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
ATYWBXGNXZYZGI-ACZMJKKPSA-N Asp-Asn-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O ATYWBXGNXZYZGI-ACZMJKKPSA-N 0.000 description 2
102000005367 Carboxypeptidases Human genes 0.000 description 2
108010006303 Carboxypeptidases Proteins 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
239000002253 acid Substances 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
210000004556 brain Anatomy 0.000 description 2
239000007853 buffer solution Substances 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
238000005520 cutting process Methods 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
QEWYKACRFQMRMB-UHFFFAOYSA-N fluoroacetic acid Chemical compound OC(=O)CF QEWYKACRFQMRMB-UHFFFAOYSA-N 0.000 description 2
238000002350 laparotomy Methods 0.000 description 2
239000007788 liquid Substances 0.000 description 2
229960005181 morphine Drugs 0.000 description 2
-1 oholecystokinin Chemical compound 0.000 description 2
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
238000000926 separation method Methods 0.000 description 2
USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
239000005695 Ammonium acetate Substances 0.000 description 1
ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
OMLWNBVRVJYMBQ-YUMQZZPRSA-N Arg-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O OMLWNBVRVJYMBQ-YUMQZZPRSA-N 0.000 description 1
UQBGYPFHWFZMCD-ZLUOBGJFSA-N Asp-Asn-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O UQBGYPFHWFZMCD-ZLUOBGJFSA-N 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
102400000748 Beta-endorphin Human genes 0.000 description 1
101800005049 Beta-endorphin Proteins 0.000 description 1
125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
241000700198 Cavia Species 0.000 description 1
101800001982 Cholecystokinin Proteins 0.000 description 1
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical class CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 1
241000581652 Hagenia abyssinica Species 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
241001529936 Murinae Species 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
108010093625 Opioid Peptides Proteins 0.000 description 1
102000001490 Opioid Peptides Human genes 0.000 description 1
108010086019 Secretin Proteins 0.000 description 1
102100037505 Secretin Human genes 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
241000282887 Suidae Species 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
210000001943 adrenal medulla Anatomy 0.000 description 1
150000001412 amines Chemical group 0.000 description 1
229940043376 ammonium acetate Drugs 0.000 description 1
235000019257 ammonium acetate Nutrition 0.000 description 1
235000012538 ammonium bicarbonate Nutrition 0.000 description 1
239000001099 ammonium carbonate Substances 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
108010068380 arginylarginine Proteins 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
WOPZMFQRCBYPJU-NTXHZHDSSA-N beta-endorphin Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C1=CC=CC=C1 WOPZMFQRCBYPJU-NTXHZHDSSA-N 0.000 description 1
239000013060 biological fluid Substances 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
FBYFHODQAUBIOO-UHFFFAOYSA-N carboxyethyl ether Natural products OC(=O)C(C)OC(C)C(O)=O FBYFHODQAUBIOO-UHFFFAOYSA-N 0.000 description 1
210000004027 cell Anatomy 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
238000000262 chemical ionisation mass spectrometry Methods 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
239000004927 clay Substances 0.000 description 1
238000004440 column chromatography Methods 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
125000001295 dansyl group Chemical group [H]C1=C([H])C(N(C([H])([H])[H])C([H])([H])[H])=C2C([H])=C([H])C([H])=C(C2=C1[H])S(*)(=O)=O 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
238000010612 desalination reaction Methods 0.000 description 1
150000004683 dihydrates Chemical class 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
238000001035 drying Methods 0.000 description 1
230000007071 enzymatic hydrolysis Effects 0.000 description 1
238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
238000011049 filling Methods 0.000 description 1
238000001914 filtration Methods 0.000 description 1
230000037406 food intake Effects 0.000 description 1
238000009472 formulation Methods 0.000 description 1
239000003629 gastrointestinal hormone Substances 0.000 description 1
239000011521 glass Substances 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
239000010439 graphite Substances 0.000 description 1
229910002804 graphite Inorganic materials 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
238000003364 immunohistochemistry Methods 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
230000007774 longterm Effects 0.000 description 1
239000006166 lysate Substances 0.000 description 1
239000000463 material Substances 0.000 description 1
230000003340 mental effect Effects 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
239000003399 opiate peptide Substances 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
229910052697 platinum Inorganic materials 0.000 description 1
239000002243 precursor Substances 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
235000018102 proteins Nutrition 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
238000003127 radioimmunoassay Methods 0.000 description 1
238000004366 reverse phase liquid chromatography Methods 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
229960002101 secretin Drugs 0.000 description 1
OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 description 1
210000000582 semen Anatomy 0.000 description 1
230000035807 sensation Effects 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000012064 sodium phosphate buffer Substances 0.000 description 1
239000002904 solvent Substances 0.000 description 1
238000003860 storage Methods 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
238000007070 tosylation reaction Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/675—Beta-endorphins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Zoology (AREA)
Toxicology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

CS825579A 1981-07-21 1982-07-21 Method of heptadecapeptide preparation CS236487B2 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP56112950A JPS5815946A (ja)	1981-07-21	1981-07-21	新規ヘプタデカペプタイド

Publications (1)

Publication Number	Publication Date
CS236487B2 true CS236487B2 (en)	1985-05-15

Family

ID=14599576

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CS825579A CS236487B2 (en)	1981-07-21	1982-07-21	Method of heptadecapeptide preparation

Country Status (8)

Country	Link
US (1)	US4481138A (da)
EP (1)	EP0070569B1 (da)
JP (1)	JPS5815946A (da)
CA (1)	CA1234565A (da)
CS (1)	CS236487B2 (da)
DE (1)	DE3264768D1 (da)
DK (1)	DK171680B1 (da)
HU (1)	HU186955B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4462941A (en)	1982-06-10	1984-07-31	The Regents Of The University Of California	Dynorphin amide analogs
US4481191A (en) *	1983-03-30	1984-11-06	The Regents Of The University Of California	Method for controlling blood pressure
US5340802A (en) *	1989-06-30	1994-08-23	Abbott Laboratories	Peptide analog type-B CCK receptor ligands
USD1056337S1 (en)	2022-07-22	2024-12-31	The Gillette Company Llc	Shaving composition applicator
CN119584888A (zh)	2022-07-22	2025-03-07	吉列有限责任公司	个人护理产品分配系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3013944A (en) *	1959-12-07	1961-12-19	Jorpes Johan Erik	Process for the production of gastrointestinal hormones and hormone concentrate
FR1605434A (da) *	1967-12-19	1975-10-17
DE2628006C2 (de) *	1976-06-23	1986-11-27	Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen	Tridecapeptid, Verfahren zu seiner Herstellung und seine Verwendung
HU175152B (hu) *	1976-12-30	1980-05-28	Richter Gedeon Vegyeszet	Sposob poluchenija peptidov s gastrin-aktivnost'ju, soderzhahhikh amino-oksi-kisloty
JPS6040412B2 (ja) *	1977-02-10	1985-09-11	エーザイ株式会社	消化管ホルモンの製造方法

1981
- 1981-07-21 JP JP56112950A patent/JPS5815946A/ja active Granted
1982
- 1982-07-20 HU HU822352A patent/HU186955B/hu not_active IP Right Cessation
- 1982-07-20 DK DK326082A patent/DK171680B1/da active
- 1982-07-20 CA CA000407628A patent/CA1234565A/en not_active Expired
- 1982-07-21 US US06/400,324 patent/US4481138A/en not_active Expired - Lifetime
- 1982-07-21 EP EP82106574A patent/EP0070569B1/en not_active Expired
- 1982-07-21 CS CS825579A patent/CS236487B2/cs unknown
- 1982-07-21 DE DE8282106574T patent/DE3264768D1/de not_active Expired

Also Published As

Publication number	Publication date
JPH032880B2 (da)	1991-01-17
CA1234565A (en)	1988-03-29
HU186955B (en)	1985-10-28
DK326082A (da)	1983-01-22
EP0070569A1 (en)	1983-01-26
DE3264768D1 (en)	1985-08-22
EP0070569B1 (en)	1985-07-17
JPS5815946A (ja)	1983-01-29
US4481138A (en)	1984-11-06
DK171680B1 (da)	1997-03-10

Publication	Publication Date	Title
Anastasi et al.	1972	Isolation and amino acid sequences of alytesin and bombesin, two analogous active tetradecapeptides from the skin of European discoglossid frogs
JP2807660B2 (ja)	1998-10-08	悪性−ＰＴＨｒＰの体液性高カルシウム血症において活性的なタンパク質
Montecucchi et al.	1980	Isolation and amino acid composition of sauvagine: an active polypeptide from methanol extracts of the skin of the South American frog Phyllomedusa sauvagei
Eysselein et al.	1982	Partial structure of a large canine cholecystokinin (CCK58): amino acid sequence
Fernandez et al.	1978	Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a.
Daly et al.	1992	Frog secretions and hunting magic in the upper Amazon: identification of a peptide that interacts with an adenosine receptor.
Said et al.	1972	Isolation from porcine‐intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon
Rossier et al.	1980	Met-enkephalin-Arg6-Phe7, present in high amounts in brain of rat, cattle and man, is an opioid agonist
Grandy et al.	1990	Purification, cloning, and tissue distribution of a 23-kDa rat protein isolated by morphine affinity chromatography
Carraway et al.	1980	Isolation, structure and biologic activity of chicken intestinal neurotensin
WO1986000078A1 (en)	1986-01-03	Inhibin isolated from ovarian follicular fluid
JP2004532604A5 (da)	2010-10-21
JPH0822876B2 (ja)	1996-03-06	ペプチドホルモンカルジオジラチン及びその製造法
CN105131084A (zh)	2015-12-09	基于内吗啡肽2或Biphalin的棕榈酰化修饰的阿片肽类似物及其合成和应用
Gregory et al.	1983	Isolation from porcine antral mucosa of a hexapeptide corresponding to the C-terminal sequence of gastrin
Fukui et al.	1983	Isolation from bovine brain of a novel analgesic pentapeptide, neo-kyotorphin, containing the Tyr-Arg (kyotorphin) unit
Keller	1981	Purification and amino acid composition of the hyperglycemic neurohormone from the sinus gland of Orconectes limosus and comparison with the hormone from Carcinus maenas
US4632780A (en)	1986-12-30	N-terminal fragment of human pro-opiomelanocortin and process therefor
Greene et al.	1977	Isolation of myocardial depressant factor from plasma of dogs in hemorrhagic shock
EP0070569B1 (en)	1985-07-17	Novel heptadecapeptide, a method for its preparation and a pharmaceutical composition containing the same
EP0486520A1 (en)	1992-05-27	FOR KAPPA OPIOID RECEPTORS SPECIFIC DYNORPHINALALOG.
Montecucchi et al.	1984	Primary structure of tryptophan‐containing peptides from skin extracts of Phyllomedusa rhodei (tryptophyllins)
Muszynska et al.	1976	Chemical modification of carboxypeptidase A crystals. Nitration of tyrosine-248
Buellesbach et al.	1986	Preparation and properties of porcine relaxin derivatives shortened at the amino terminus of the A-chain
US4119618A (en)	1978-10-10	Vasoactive polypeptide and method of preparation from neural tissue